Phase 2a Study of Baxdrostat in Primary Aldosteronism

By afschroeder • July 15, 2025

Turcu AF, Freeman MW, Bancos I, Ben-Shlomo A, Hamidi O, Hamrahian AH, Huang W, Kirschner LS, Sam R, Mallappa A, Tuyishimire B, Lihn AS, Perl S, Brown MJ; SPARK Investigator Group. Phase 2a Study of Baxdrostat in Primary Aldosteronism. N Engl J Med. 2025 Jul 13. doi: 10.1056/NEJMc2508629. Epub ahead of print. PMID: 40658651.

Tags: Cedars Sinai DoM, Endocrinology, Publications

Modulation of the PTPRS proteoglycan switch by antibodies binding to the membrane-proximal fibronectin-type III domain

Hein Da Rosa T, Ramsey SH, Lee JJ, Kozlova NY, Zhao Z, Kim J, Schneider AC, Li S, Katiki M, Firestein GS, Murali R, Santelli[...]

Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases

Gamez J, Zha D, Ebrahimi SM, White S, Ljubimov AV, Saghizadeh M. Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases. Cells. 2025 Jun[...]

Leveraging A Randomized Trial to Assess Relationships between Transeptal Puncture, Brain Emboli, and Migraine Symptoms

Elias A, Tung R, Gerstenfeld EP, Hue TF, Lin F, Cheng J, Weiss JP, Tzou WS, Hsia H, Ehdaie A, Cooper DH, Bunch TJ, Arkles[...]